A Retrospective/Prospective Analysis of Characterization of the Long-Term Responders on Olaparib in Solid Tumours
This is an observational and sample collection study involving patients (alive or deceased)
from several clinical trials who had received the investigational drug, olaparib in other
research studies. There is no intervention given for this study.
This research is being done to understand of the mechanisms involved in patients whose
cancer responds well and whose cancer does not respond well to investigational drug,
olaparib, to help better understand how olaparib works and to better identify patients who
may benefit from this therapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society